Russell Investments Group Ltd. raised its holdings in Vitamin Shoppe, Inc (NYSE:VSI) by 16.7% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 26,788 shares of the specialty retailer’s stock after buying an additional 3,839 shares during the period. Russell Investments Group Ltd. owned 0.12% of Vitamin Shoppe worth $312,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of the business. Arizona State Retirement System increased its stake in Vitamin Shoppe by 0.8% in the 1st quarter. Arizona State Retirement System now owns 12,360 shares of the specialty retailer’s stock valued at $249,000 after buying an additional 100 shares during the last quarter. Mason Street Advisors LLC increased its stake in Vitamin Shoppe by 7.0% in the 1st quarter. Mason Street Advisors LLC now owns 5,569 shares of the specialty retailer’s stock valued at $112,000 after buying an additional 366 shares during the last quarter. Capstone Asset Management Co. increased its stake in Vitamin Shoppe by 3.5% in the 2nd quarter. Capstone Asset Management Co. now owns 14,040 shares of the specialty retailer’s stock valued at $164,000 after buying an additional 470 shares during the last quarter. Thrivent Financial For Lutherans increased its stake in Vitamin Shoppe by 1.5% in the 1st quarter. Thrivent Financial For Lutherans now owns 37,070 shares of the specialty retailer’s stock valued at $747,000 after buying an additional 560 shares during the last quarter. Finally, Credit Suisse AG increased its stake in Vitamin Shoppe by 1.2% in the 1st quarter. Credit Suisse AG now owns 72,256 shares of the specialty retailer’s stock valued at $1,456,000 after buying an additional 863 shares during the last quarter. Hedge funds and other institutional investors own 96.86% of the company’s stock.

Several brokerages have issued reports on VSI. ValuEngine lowered shares of Vitamin Shoppe from a “buy” rating to a “hold” rating in a research note on Friday, September 1st. Zacks Investment Research upgraded shares of Vitamin Shoppe from a “strong sell” rating to a “hold” rating in a research note on Tuesday, July 18th. Goldman Sachs Group, Inc. (The) reiterated a “sell” rating and issued a $6.00 price target (down from $13.00) on shares of Vitamin Shoppe in a research note on Thursday, August 10th. TheStreet lowered shares of Vitamin Shoppe from a “c-” rating to a “d” rating in a research note on Wednesday, August 9th. Finally, Deutsche Bank AG reiterated a “hold” rating and issued a $7.00 price target (down from $14.00) on shares of Vitamin Shoppe in a research note on Thursday, August 10th. Four research analysts have rated the stock with a sell rating and seven have given a hold rating to the stock. The company currently has a consensus rating of “Hold” and a consensus target price of $14.38.

Shares of Vitamin Shoppe, Inc (NYSE VSI) traded up 1.90% on Friday, hitting $5.35. 256,688 shares of the stock were exchanged. Vitamin Shoppe, Inc has a 1-year low of $4.95 and a 1-year high of $28.41. The stock’s 50-day moving average is $6.38 and its 200-day moving average is $12.76. The stock’s market cap is $124.24 million.

Vitamin Shoppe (NYSE:VSI) last announced its earnings results on Wednesday, August 9th. The specialty retailer reported $0.23 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.39 by ($0.16). The firm had revenue of $304.84 million during the quarter, compared to analysts’ expectations of $314.74 million. Vitamin Shoppe had a negative net margin of 11.98% and a positive return on equity of 8.33%. The business’s revenue for the quarter was down 8.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.55 EPS. Analysts forecast that Vitamin Shoppe, Inc will post $0.79 earnings per share for the current year.

In other news, Director John D. Bowlin bought 40,000 shares of the stock in a transaction dated Friday, August 25th. The stock was bought at an average price of $5.50 per share, for a total transaction of $220,000.00. Following the completion of the acquisition, the director now directly owns 56,028 shares in the company, valued at approximately $308,154. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 1.07% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Russell Investments Group Ltd. Acquires 3,839 Shares of Vitamin Shoppe, Inc (VSI)” was first published by Daily Political and is owned by of Daily Political. If you are viewing this news story on another domain, it was illegally stolen and reposted in violation of international trademark and copyright legislation. The original version of this news story can be read at https://www.dailypolitical.com/2017/09/24/russell-investments-group-ltd-acquires-3839-shares-of-vitamin-shoppe-inc-vsi.html.

Vitamin Shoppe Company Profile

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.

Institutional Ownership by Quarter for Vitamin Shoppe (NYSE:VSI)

Receive News & Ratings for Vitamin Shoppe Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc and related companies with MarketBeat.com's FREE daily email newsletter.